increased use of spironolactone for heart failure is causing more hospitalizations and deaths

The increased use of spironolactone for heart failure is causing more hospitalizations and deaths.

The problem started a few years ago when a large well-respected study showed that spironolactone improved survival in patients with severe heart failure.

This was the Randomized Aldactone Evaluation Study (RALES).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote